NEW DELHI: Tomorrow Capital, a $100 million VC fund, is investing $2.7 million in VitusCare as a part of its Series A funding spherical.
VitusCare, a kidney care start-up based in 2017, has emerged as a participant of high quality dialysis care, notably in areas the place entry to such providers is proscribed, an organization assertion stated.
The recent capital injection will empower VitusCare to aggressively broaden its operations, with a focused give attention to deeper penetration into the hinterland.
In addition, the funding spherical noticed participation from current investor 1Crowd, alongside help from 3i Partners and a consortium of angel buyers, totalling roughly $5 million in funding throughout all of the funding rounds.
Tomorrow Capital, a part of Lodha Ventures, has investments in healthcare, health and schooling.
India has over 5 million sufferers affected by ESRD (end-stage renal illness), nevertheless, solely about 5% of those obtain common dialysis with causes starting from affordability, lack of information and entry. Even at the moment, most dialysis providers are skewed in the direction of the larger cities, additional compounding this downside.
VitusCare, a kidney care start-up based in 2017, has emerged as a participant of high quality dialysis care, notably in areas the place entry to such providers is proscribed, an organization assertion stated.
The recent capital injection will empower VitusCare to aggressively broaden its operations, with a focused give attention to deeper penetration into the hinterland.
In addition, the funding spherical noticed participation from current investor 1Crowd, alongside help from 3i Partners and a consortium of angel buyers, totalling roughly $5 million in funding throughout all of the funding rounds.
Tomorrow Capital, a part of Lodha Ventures, has investments in healthcare, health and schooling.
India has over 5 million sufferers affected by ESRD (end-stage renal illness), nevertheless, solely about 5% of those obtain common dialysis with causes starting from affordability, lack of information and entry. Even at the moment, most dialysis providers are skewed in the direction of the larger cities, additional compounding this downside.
